Go Pro

Atlanta Braves (BATRA) Financials

Atlanta Braves logo
$56.36 -0.30 (-0.53%)
Closing price 07/20/2026 04:00 PM Eastern
Extended Trading
$56.35 -0.01 (-0.02%)
As of 07/20/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Atlanta Braves

Annual Income Statements for Atlanta Braves

This table shows Atlanta Braves' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-34 -125 -31 -23
Consolidated Net Income / (Loss)
-34 -125 -31 -23
Net Income / (Loss) Continuing Operations
-34 -125 -31 -23
Total Pre-Tax Income
-32 -129 -36 -24
Total Operating Income
-31 -46 -40 -14
Total Gross Profit
589 149 149 732
Total Revenue
589 641 663 732
Operating Revenue
589 641 663 732
Total Cost of Revenue
0.00 491 514 0.00
Total Operating Expenses
599 194 189 746
Selling, General & Admin Expense
106 125 126 129
Depreciation Expense
72 71 63 76
Other Operating Expenses / (Income)
437 - - 511
Impairment Charge
5.43 0.00 0.00 30
Other Special Charges / (Income)
-20 -2.31 0.00 0.00
Total Other Income / (Expense), net
-21 -85 3.72 -11
Interest Expense
30 38 39 46
Interest & Investment Income
42 29 34 28
Other Income / (Expense), net
-33 -77 8.63 7.42
Income Tax Expense
2.66 -3.86 -4.67 -0.83
Net Income / (Loss) Attributable to Noncontrolling Interest
- 0.00 0.00 0.09
Basic Earnings per Share
($0.55) ($2.03) ($0.50) ($0.37)
Weighted Average Basic Shares Outstanding
- 61.87M 62.57M 63.91M
Diluted Earnings per Share
($0.55) ($2.03) ($0.50) ($0.37)
Weighted Average Diluted Shares Outstanding
- 61.87M 62.57M 63.91M
Weighted Average Basic & Diluted Shares Outstanding
- 61.87M 62.57M 63.91M

Quarterly Income Statements for Atlanta Braves

This table shows Atlanta Braves' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-6.05 -32 -51 29 10 -19 -41 29 30 -41 -40
Consolidated Net Income / (Loss)
-6.05 -32 -51 29 10 -19 -41 29 30 -41 -40
Net Income / (Loss) Continuing Operations
-6.05 -32 -51 29 10 -19 -41 29 30 -41 -40
Total Pre-Tax Income
2.21 -38 -55 30 9.91 -20 -54 42 42 -54 -51
Total Operating Income
16 -32 -52 25 6.40 -19 -44 42 39 -50 -41
Total Gross Profit
272 -385 37 283 62 -233 47 312 312 61 11
Total Revenue
272 68 37 283 291 52 47 312 312 61 72
Operating Revenue
272 68 37 283 291 52 47 312 312 61 72
Total Cost of Revenue
0.00 453 0.00 0.00 228 285 0.00 0.00 0.00 - 61
Operating Cost of Revenue
- - - - 228 - - - - - 61
Total Operating Expenses
256 -355 89 258 56 -215 92 271 273 111 52
Selling, General & Admin Expense
34 30 27 33 37 28 27 35 35 32 35
Depreciation Expense
21 16 15 17 19 12 13 21 23 18 17
Total Other Income / (Expense), net
-14 -8.27 -3.07 5.06 3.50 -1.76 -9.45 -0.01 2.88 -4.01 -9.37
Interest Expense
9.66 9.66 9.44 9.71 9.56 10 10 12 12 12 11
Interest & Investment Income
15 0.27 4.60 13 11 5.50 -0.32 9.97 13 5.30 0.61
Other Income / (Expense), net
-19 1.12 1.77 2.22 1.84 2.81 1.21 1.67 1.69 2.85 1.19
Income Tax Expense
8.26 -5.97 -4.16 0.88 -0.12 -1.29 -13 12 12 -12 -10
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - 0.00 - 0.00 - 0.12 - 0.06
Basic Earnings per Share
($0.10) ($0.52) ($0.83) $0.47 $0.16 ($0.30) ($0.66) $0.47 $0.48 ($0.66) ($0.63)
Weighted Average Basic Shares Outstanding
61.72M 61.87M 61.94M 61.97M 62.14M 62.57M 62.59M 62.76M 62.92M 63.91M 64.14M
Diluted Earnings per Share
($0.10) ($0.52) ($0.83) $0.46 $0.16 ($0.29) ($0.66) $0.46 $0.47 ($0.64) ($0.63)
Weighted Average Diluted Shares Outstanding
61.72M 61.87M 61.94M 61.97M 62.14M 62.57M 62.59M 62.76M 62.92M 63.91M 64.14M
Weighted Average Basic & Diluted Shares Outstanding
61.72M 61.87M 61.94M 61.97M 62.14M 62.57M 62.59M 62.76M 62.92M 63.91M 64.14M

Annual Cash Flow Statements for Atlanta Braves

This table details how cash moves in and out of Atlanta Braves' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-71 -35 -25 -1.02
Net Cash From Operating Activities
53 1.63 17 25
Net Cash From Continuing Operating Activities
53 1.63 17 25
Net Income / (Loss) Continuing Operations
-34 -125 -31 -23
Consolidated Net Income / (Loss)
-34 -125 -31 -23
Depreciation Expense
72 71 63 76
Non-Cash Adjustments To Reconcile Net Income
13 94 12 47
Changes in Operating Assets and Liabilities, net
2.92 -38 -27 -74
Net Cash From Investing Activities
53 -69 -86 -145
Net Cash From Continuing Investing Activities
53 -69 -86 -145
Purchase of Property, Plant & Equipment
-18 -69 -86 -145
Acquisitions
-5.27 -0.13 -0.33 0.00
Other Investing Activities, net
28 0.11 0.04 0.01
Net Cash From Financing Activities
-177 32 45 119
Net Cash From Continuing Financing Activities
-177 32 45 119
Repayment of Debt
-318 -62 -107 -48
Issuance of Debt
155 83 145 158
Issuance of Common Equity
0.00 12 0.00 0.00
Other Financing Activities, net
-14 -0.69 6.41 9.06

Quarterly Cash Flow Statements for Atlanta Braves

This table details how cash moves in and out of Atlanta Braves' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-56 11 71 -48 -45 -3.42 154 -113 -39 -3.04 57
Net Cash From Operating Activities
-57 23 91 -34 -69 29 96 -8.13 -89 26 62
Net Cash From Continuing Operating Activities
-57 23 91 -34 -69 29 96 -8.13 -89 26 62
Net Income / (Loss) Continuing Operations
-6.05 -32 -51 29 10 -19 -41 29 30 -41 -40
Consolidated Net Income / (Loss)
-6.05 -32 -51 29 10 -19 -41 29 30 -41 -40
Depreciation Expense
21 16 15 17 19 12 13 21 23 18 17
Non-Cash Adjustments To Reconcile Net Income
18 15 0.79 -3.12 5.26 8.96 6.01 0.43 -0.44 41 6.63
Changes in Operating Assets and Liabilities, net
-91 24 127 -77 -103 27 118 -59 -142 9.02 79
Net Cash From Investing Activities
-16 -24 -28 -31 -16 -12 -22 -109 -7.56 -7.37 -8.63
Net Cash From Continuing Investing Activities
-16 -24 -28 -31 -16 -12 -22 -109 -7.56 -7.37 -8.63
Purchase of Property, Plant & Equipment
-16 -24 -28 -30 -16 -12 -20 -111 -7.56 -7.37 -8.63
Other Investing Activities, net
-0.13 0.13 0.05 -0.01 -0.33 0.33 -2.00 2.01 0.00 - 0.01
Net Cash From Financing Activities
17 12 7.83 17 40 -20 80 3.35 57 -22 3.42
Net Cash From Continuing Financing Activities
17 12 7.83 17 40 -20 80 3.35 57 -22 3.42
Repayment of Debt
-20 -18 -5.96 -1.43 -35 -65 -6.04 -4.91 -10 -28 -23
Issuance of Debt
36 31 14 20 73 39 86 3.01 65 4.65 0.00
Other Financing Activities, net
- - - - 1.44 6.00 0.68 - 2.72 1.09 27

Annual Balance Sheets for Atlanta Braves

This table presents Atlanta Braves' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,491 1,504 1,524 1,615
Total Current Assets
267 218 179 159
Cash & Equivalents
151 125 110 100
Restricted Cash
22 13 2.46 12
Accounts Receivable
70 63 50 34
Other Current Assets
24 17 17 14
Plant, Property, & Equipment, net
730 767 807 869
Plant, Property & Equipment, gross
1,008 1,092 1,162 1,266
Accumulated Depreciation
278 325 354 397
Total Noncurrent Assets
493 520 537 587
Long-Term Investments
95 99 109 117
Goodwill
176 176 176 176
Intangible Assets
124 124 124 124
Employee Benefit Assets
- - - 0.00
Other Noncurrent Operating Assets
99 121 129 171
Total Liabilities & Shareholders' Equity
1,491 1,504 1,524 1,615
Total Liabilities
1,191 964 988 1,077
Total Current Liabilities
241 234 287 377
Short-Term Debt
75 42 104 215
Accounts Payable
55 73 64 43
Current Deferred Revenue
105 112 112 110
Other Current Liabilities
6.36 6.44 6.91 8.39
Total Noncurrent Liabilities
950 730 701 700
Long-Term Debt
467 527 513 523
Noncurrent Deferred & Payable Income Tax Liabilities
54 50 44 41
Noncurrent Employee Benefit Liabilities
15 15 6.56 1.76
Other Noncurrent Operating Liabilities
414 137 138 133
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
300 541 536 538
Total Preferred & Common Equity
300 529 524 526
Preferred Stock
0.00 0.00 0.00 0.00
Total Common Equity
300 529 524 526
Common Stock
0.00 1,090 1,113 1,138
Retained Earnings
-429 -554 -586 -609
Accumulated Other Comprehensive Income / (Loss)
-3.76 -7.27 -3.35 -2.74
Noncontrolling Interest
0.00 12 12 12

Quarterly Balance Sheets for Atlanta Braves

This table presents Atlanta Braves' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
1,519 1,602 1,574 1,557 1,681 1,684 1,671 1,687
Total Current Assets
244 287 248 224 321 237 217 225
Cash & Equivalents
107 181 121 101 245 96 82 135
Restricted Cash
20 28 40 15 22 57 32 34
Accounts Receivable
99 40 59 88 28 61 87 30
Other Current Assets
18 38 28 20 27 22 16 26
Plant, Property, & Equipment, net
749 788 801 801 819 881 878 874
Plant, Property & Equipment, gross
1,062 1,127 1,150 1,160 1,184 1,260 1,270 1,281
Accumulated Depreciation
312 339 349 359 366 379 392 407
Total Noncurrent Assets
526 526 524 532 542 566 577 589
Long-Term Investments
106 100 107 114 109 115 121 116
Goodwill
176 176 176 176 176 176 176 176
Intangible Assets
124 124 124 124 124 124 124 124
Employee Benefit Assets
- - - - - - - 0.52
Other Noncurrent Operating Assets
120 127 118 119 133 152 156 172
Total Liabilities & Shareholders' Equity
1,519 1,602 1,574 1,557 1,681 1,684 1,671 1,687
Total Liabilities
943 1,111 1,049 1,015 1,183 1,149 1,099 1,156
Total Current Liabilities
189 360 388 322 414 371 250 491
Short-Term Debt
7.79 43 138 138 104 104 105 216
Accounts Payable
68 99 99 93 82 111 66 86
Current Deferred Revenue
106 212 146 82 220 144 73 181
Other Current Liabilities
7.06 5.84 4.73 9.09 7.11 11 6.18 8.02
Total Noncurrent Liabilities
754 751 661 693 769 778 849 665
Long-Term Debt
547 537 462 502 595 599 655 493
Noncurrent Deferred & Payable Income Tax Liabilities
57 57 48 40 31 38 55 31
Noncurrent Employee Benefit Liabilities
11 13 13 11 4.28 4.39 2.08 0.00
Other Noncurrent Operating Liabilities
139 144 138 139 139 137 138 141
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
576 491 525 542 498 535 572 531
Total Preferred & Common Equity
564 479 513 530 486 523 560 519
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
564 479 513 530 486 523 560 519
Common Stock
1,089 1,092 1,097 1,104 1,117 1,124 1,131 1,171
Retained Earnings
-522 -606 -577 -567 -627 -598 -568 -649
Accumulated Other Comprehensive Income / (Loss)
-3.51 -7.34 -7.43 -7.50 -3.34 -3.35 -3.34 -2.74
Noncontrolling Interest
12 12 12 12 12 12 12 12

Annual Metrics And Ratios for Atlanta Braves

This table displays calculated financial ratios and metrics derived from Atlanta Braves' official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 61,723,829.00 62,138,584.00 62,923,320.00
DEI Adjusted Shares Outstanding
0.00 61,723,829.00 62,138,584.00 62,923,320.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -2.03 -0.50 -0.37
Growth Metrics
- - - -
Revenue Growth
0.00% 8.85% 3.45% 10.52%
EBITDA Growth
0.00% -782.84% 160.97% 118.70%
EBIT Growth
0.00% -92.19% 74.79% 80.33%
NOPAT Growth
0.00% -51.86% 14.59% 65.90%
Net Income Growth
0.00% -266.66% 75.04% 25.54%
EPS Growth
0.00% -269.09% 75.37% 26.00%
Operating Cash Flow Growth
0.00% -96.95% 922.82% 51.74%
Free Cash Flow Firm Growth
0.00% 0.00% 73.82% -45.17%
Invested Capital Growth
0.00% 52.06% 6.76% 12.50%
Revenue Q/Q Growth
0.00% 0.00% -2.30% 1.27%
EBITDA Q/Q Growth
0.00% 0.00% 59.04% -26.93%
EBIT Q/Q Growth
0.00% 0.00% 33.18% -124.42%
NOPAT Q/Q Growth
0.00% 0.00% 25.70% -441.99%
Net Income Q/Q Growth
0.00% 0.00% 29.74% -2,430.54%
EPS Q/Q Growth
0.00% 0.00% 31.51% -1,750.00%
Operating Cash Flow Q/Q Growth
0.00% -87.15% 56.01% -8.99%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 13.58%
Invested Capital Q/Q Growth
0.00% 0.00% -2.17% -4.39%
Profitability Metrics
- - - -
Gross Margin
100.00% 23.33% 22.46% 100.00%
EBITDA Margin
1.30% -8.14% 4.80% 9.49%
Operating Margin
-5.20% -7.25% -5.98% -1.85%
EBIT Margin
-10.88% -19.22% -4.68% -0.83%
Profit (Net Income) Margin
-5.81% -19.56% -4.72% -3.18%
Tax Burden Percent
108.42% 97.01% 87.00% 96.55%
Interest Burden Percent
49.20% 104.90% 115.80% 395.02%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-3.73% -4.49% -3.08% -0.96%
ROIC Less NNEP Spread (ROIC-NNEP)
-8.38% -35.07% -4.04% -4.01%
Return on Net Nonoperating Assets (RNNOA)
-7.68% -25.33% -2.73% -3.38%
Return on Equity (ROE)
-11.41% -29.83% -5.81% -4.33%
Cash Return on Invested Capital (CROIC)
0.00% -45.80% -9.61% -12.72%
Operating Return on Assets (OROA)
-4.30% -8.22% -2.05% -0.39%
Return on Assets (ROA)
-2.29% -8.37% -2.07% -1.48%
Return on Common Equity (ROCE)
-11.41% -29.40% -5.68% -4.24%
Return on Equity Simple (ROE_SIMPLE)
-11.41% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-21 -33 -28 -9.47
NOPAT Margin
-3.64% -5.07% -4.19% -1.29%
Net Nonoperating Expense Percent (NNEP)
4.65% 30.58% 0.96% 3.05%
Return On Investment Capital (ROIC_SIMPLE)
-2.54% -2.93% -2.41% -0.74%
Cost of Revenue to Revenue
0.00% 76.67% 77.54% 0.00%
SG&A Expenses to Revenue
17.93% 19.50% 18.96% 17.60%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
101.78% 30.21% 28.44% 101.85%
Earnings before Interest and Taxes (EBIT)
-64 -123 -31 -6.10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
7.64 -52 32 70
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 5.00 4.84 5.08
Price to Tangible Book Value (P/TBV)
0.00 11.52 11.28 11.80
Price to Revenue (P/Rev)
0.00 4.12 3.83 3.65
Price to Earnings (P/E)
0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 3.42 3.16 3.05
Enterprise Value to Revenue (EV/Rev)
0.00 4.66 4.44 4.36
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 92.57 45.97
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 1,835.75 176.96 126.64
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
1.81 1.05 1.15 1.37
Long-Term Debt to Equity
1.56 0.98 0.96 0.97
Financial Leverage
0.92 0.72 0.68 0.84
Leverage Ratio
4.98 3.56 2.81 2.92
Compound Leverage Factor
2.45 3.74 3.26 11.54
Debt to Total Capital
64.41% 51.29% 53.51% 57.85%
Short-Term Debt to Total Capital
8.89% 3.80% 9.03% 16.87%
Long-Term Debt to Total Capital
55.52% 47.49% 44.47% 40.98%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 1.09% 1.04% 0.95%
Common Equity to Total Capital
35.59% 47.63% 45.45% 41.20%
Debt to EBITDA
70.98 -10.92 19.41 10.62
Net Debt to EBITDA
35.96 -6.37 12.45 7.34
Long-Term Debt to EBITDA
61.18 -10.11 16.13 7.53
Debt to NOPAT
-25.32 -17.51 -22.23 -78.01
Net Debt to NOPAT
-12.83 -10.22 -14.25 -53.89
Long-Term Debt to NOPAT
-21.82 -16.22 -18.47 -55.26
Altman Z-Score
0.00 1.27 1.29 1.24
Noncontrolling Interest Sharing Ratio
0.00% 1.43% 2.24% 2.25%
Liquidity Ratios
- - - -
Current Ratio
1.11 0.93 0.62 0.42
Quick Ratio
0.92 0.80 0.56 0.35
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 -331 -87 -126
Operating Cash Flow to CapEx
0.00% 2.36% 19.34% 17.40%
Free Cash Flow to Firm to Interest Expense
0.00 -8.80 -2.24 -2.71
Operating Cash Flow to Interest Expense
1.80 0.04 0.43 0.54
Operating Cash Flow Less CapEx to Interest Expense
2.83 -1.79 -1.79 -2.58
Efficiency Ratios
- - - -
Asset Turnover
0.39 0.43 0.44 0.47
Accounts Receivable Turnover
8.38 9.62 11.74 17.53
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.81 0.86 0.84 0.87
Accounts Payable Turnover
0.00 7.68 7.51 0.00
Days Sales Outstanding (DSO)
43.56 37.93 31.09 20.82
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 47.50 48.58 0.00
Cash Conversion Cycle (CCC)
43.56 -9.57 -17.49 20.82
Capital & Investment Metrics
- - - -
Invested Capital
574 873 932 1,048
Invested Capital Turnover
1.03 0.89 0.73 0.74
Increase / (Decrease) in Invested Capital
0.00 299 59 116
Enterprise Value (EV)
0.00 2,985 2,943 3,196
Market Capitalization
0.00 2,641 2,535 2,674
Book Value per Share
$0.00 $8.56 $8.44 $8.36
Tangible Book Value per Share
$0.00 $3.71 $3.62 $3.60
Total Capital
841 1,110 1,153 1,277
Total Debt
542 569 617 739
Total Long-Term Debt
467 527 513 523
Net Debt
275 332 396 510
Capital Expenditures (CapEx)
-30 69 86 145
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-72 -111 -116 -115
Debt-free Net Working Capital (DFNWC)
101 26 -3.32 -2.99
Net Working Capital (NWC)
26 -16 -108 -218
Net Nonoperating Expense (NNE)
13 93 3.50 14
Net Nonoperating Obligations (NNO)
275 332 396 510
Total Depreciation and Amortization (D&A)
72 71 63 76
Debt-free, Cash-free Net Working Capital to Revenue
-12.16% -17.36% -17.49% -15.64%
Debt-free Net Working Capital to Revenue
17.21% 4.14% -0.50% -0.41%
Net Working Capital to Revenue
4.50% -2.44% -16.22% -29.81%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 ($2.03) ($0.50) ($0.37)
Adjusted Weighted Average Basic Shares Outstanding
0.00 61.87M 62.57M 63.91M
Adjusted Diluted Earnings per Share
$0.00 ($2.03) ($0.50) ($0.37)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 61.87M 62.57M 63.91M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 61.87M 62.57M 63.91M
Normalized Net Operating Profit after Tax (NOPAT)
-32 -34 -28 12
Normalized NOPAT Margin
-5.39% -5.33% -4.19% 1.59%
Pre Tax Income Margin
-5.35% -20.16% -5.42% -3.29%
Debt Service Ratios
- - - -
EBIT to Interest Expense
-2.17 -3.27 -0.80 -0.13
NOPAT to Interest Expense
-0.72 -0.86 -0.72 -0.20
EBIT Less CapEx to Interest Expense
-1.14 -5.10 -3.02 -3.25
NOPAT Less CapEx to Interest Expense
0.30 -2.70 -2.93 -3.33
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Atlanta Braves

This table displays calculated financial ratios and metrics derived from Atlanta Braves' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
0.00 61,723,829.00 61,873,749.00 61,939,820.00 61,972,169.00 62,138,584.00 62,565,828.00 62,593,048.00 62,755,203.00 62,923,320.00 63,914,890.00
DEI Adjusted Shares Outstanding
0.00 61,723,829.00 61,873,749.00 61,939,820.00 61,972,169.00 62,138,584.00 62,565,828.00 62,593,048.00 62,755,203.00 62,923,320.00 63,914,890.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -0.52 -0.83 0.47 0.16 -0.31 -0.66 0.47 0.48 -0.66 -0.63
Growth Metrics
- - - - - - - - - - -
Revenue Growth
10.75% 0.00% 19.72% 4.72% 6.93% -23.07% 27.32% 10.45% 7.18% 17.62% 52.52%
EBITDA Growth
226.16% 0.00% 24.22% 700.08% 50.94% 76.22% 16.03% 46.25% 138.08% -695.68% 23.52%
EBIT Growth
90.27% 0.00% 18.14% 201.98% 338.70% 49.30% 14.52% 60.06% 392.94% -196.30% 7.36%
NOPAT Growth
-1,209.88% 0.00% -6.29% 77.60% 115.05% 42.38% 15.10% 21.89% 332.84% -167.01% 7.20%
Net Income Growth
79.77% 0.00% 11.56% 200.68% 265.70% 40.90% 19.27% 1.32% 200.42% -116.92% 2.33%
EPS Growth
79.17% 0.00% 11.70% 197.87% 260.00% 44.23% 20.48% 0.00% 193.75% -120.69% 4.55%
Operating Cash Flow Growth
0.00% -32.48% 7.69% 29.51% -20.68% 26.04% 5.17% 76.31% -28.67% -8.62% -34.76%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 94.97% 0.00% 88.63% 89.88% -144.80% -110.06% -78.67%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 5.99% 6.76% 7.84% 13.28% 15.11% 12.50% 16.24%
Revenue Q/Q Growth
0.63% -75.08% -45.27% 662.88% 2.76% -82.07% -9.42% 561.79% -0.29% -80.32% 17.46%
EBITDA Q/Q Growth
341.78% -186.83% -130.56% 223.97% -39.18% -113.68% -714.06% 315.90% -1.00% -145.73% 21.75%
EBIT Q/Q Growth
87.04% -805.30% -61.87% 153.68% -69.65% -292.27% -172.92% 200.51% -6.54% -215.57% 14.67%
NOPAT Q/Q Growth
-415.71% 47.34% -61.76% 166.04% -73.24% -301.56% -138.37% 194.80% -4.97% -224.34% 17.15%
Net Income Q/Q Growth
79.09% -435.11% -58.45% 156.77% -65.58% -290.87% -116.42% 171.26% 2.06% -237.82% 2.56%
EPS Q/Q Growth
78.72% -420.00% -59.62% 155.42% -65.22% -281.25% -127.59% 169.70% 2.17% -236.17% 1.56%
Operating Cash Flow Q/Q Growth
-17.51% 140.09% 297.10% -137.68% -101.17% 141.87% 231.35% -108.49% -992.44% 129.74% 136.57%
Free Cash Flow Firm Q/Q Growth
0.00% 100.00% 0.00% -4.16% 94.31% -52.09% -26.12% 7.35% -37.74% -30.51% -7.27%
Invested Capital Q/Q Growth
0.00% -2.87% -12.71% 12.35% 11.28% -2.17% -11.83% 18.01% 13.08% -4.39% -8.89%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% -567.95% 100.00% 100.00% 21.40% -447.67% 100.00% 100.00% 100.00% 100.00% 15.46%
EBITDA Margin
6.56% -22.86% -96.29% 15.65% 9.26% -7.07% -63.51% 20.72% 20.57% -47.80% -31.85%
Operating Margin
5.78% -47.77% -141.19% 8.82% 2.20% -35.78% -94.16% 13.37% 12.50% -81.22% -57.29%
EBIT Margin
-1.27% -46.13% -136.42% 9.60% 2.83% -30.40% -91.59% 13.91% 13.04% -76.58% -55.63%
Profit (Net Income) Margin
-2.22% -47.76% -138.27% 10.29% 3.45% -36.70% -87.67% 9.44% 9.66% -67.67% -56.14%
Tax Burden Percent
-273.74% 84.43% 92.50% 97.05% 101.16% 93.70% 76.80% 70.59% 72.01% 77.11% 79.86%
Interest Burden Percent
-63.99% 122.64% 109.57% 110.46% 120.21% 128.83% 124.65% 96.14% 102.92% 114.61% 126.37%
Effective Tax Rate
373.74% 0.00% 0.00% 2.95% -1.16% 0.00% 0.00% 29.41% 27.99% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -24.54% -167.78% 13.18% 1.63% -18.39% -56.01% 7.26% 6.35% -42.06% -34.18%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -27.46% -178.58% 16.14% 2.60% -20.06% -59.46% 7.26% 6.80% -43.52% -37.27%
Return on Net Nonoperating Assets (RNNOA)
0.00% -16.88% -98.43% 10.20% 1.70% -13.56% -35.72% 5.25% 5.69% -36.70% -27.07%
Return on Equity (ROE)
0.00% -41.42% -266.21% 23.38% 3.34% -31.96% -91.72% 12.52% 12.05% -78.76% -61.25%
Cash Return on Invested Capital (CROIC)
0.00% -37.96% 0.00% 0.00% 0.00% -9.61% -10.35% -13.59% -14.22% -12.72% -15.83%
Operating Return on Assets (OROA)
0.00% -19.73% -55.07% 8.05% 1.25% -13.31% -37.54% 6.00% 5.84% -35.74% -25.01%
Return on Assets (ROA)
0.00% -20.43% -55.82% 8.62% 1.52% -16.06% -35.93% 4.07% 4.33% -31.59% -25.24%
Return on Common Equity (ROCE)
0.00% -40.83% -259.68% 22.84% 3.27% -31.24% -89.49% 12.23% 11.78% -76.99% -59.81%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% -24.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-43 -23 -37 24 6.48 -13 -31 29 28 -35 -29
NOPAT Margin
-15.83% -33.44% -98.84% 8.56% 2.23% -25.05% -65.91% 9.44% 9.00% -56.86% -40.10%
Net Nonoperating Expense Percent (NNEP)
-22.89% 2.92% 10.80% -2.96% -0.97% 1.67% 3.46% 0.00% -0.44% 1.46% 3.09%
Return On Investment Capital (ROIC_SIMPLE)
- -2.04% -3.42% 2.15% 0.55% -1.13% -2.60% 2.38% 2.10% -2.73% -2.33%
Cost of Revenue to Revenue
0.00% 667.95% 0.00% 0.00% 78.60% 547.67% 0.00% 0.00% 0.00% 0.00% 84.54%
SG&A Expenses to Revenue
12.65% 44.28% 73.07% 11.79% 12.77% 53.94% 57.69% 11.18% 11.16% 52.16% 48.96%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
94.22% -523.58% 241.19% 91.18% 19.20% -411.89% 194.16% 86.63% 87.50% 181.22% 72.75%
Earnings before Interest and Taxes (EBIT)
-3.45 -31 -51 27 8.24 -16 -43 43 41 -47 -40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
18 -15 -36 44 27 -3.68 -30 65 64 -29 -23
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 5.00 5.41 4.99 4.92 4.84 5.65 5.89 5.09 5.08 5.81
Price to Tangible Book Value (P/TBV)
0.00 11.52 14.42 12.01 11.31 11.28 14.71 13.79 10.94 11.80 13.73
Price to Revenue (P/Rev)
0.00 4.12 4.01 3.88 3.85 3.83 4.08 4.39 3.95 3.65 3.98
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 3.42 3.77 3.39 3.19 3.16 3.75 3.64 3.09 3.05 3.61
Enterprise Value to Revenue (EV/Rev)
0.00 4.66 4.45 4.40 4.47 4.44 4.58 5.02 4.69 4.36 4.56
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 266.22 151.79 92.57 82.11 60.83 35.62 45.97 45.05
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 135.61 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 1,835.75 353.88 129.12 284.65 176.96 144.37 74.23 122.25 126.64 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.96 1.05 1.18 1.14 1.18 1.15 1.40 1.31 1.33 1.37 1.34
Long-Term Debt to Equity
0.95 0.98 1.09 0.88 0.93 0.96 1.19 1.12 1.14 0.97 0.93
Financial Leverage
0.56 0.61 0.55 0.63 0.66 0.68 0.60 0.72 0.84 0.84 0.73
Leverage Ratio
2.64 3.56 3.26 3.00 2.75 2.81 3.32 3.07 2.90 2.92 3.27
Compound Leverage Factor
-1.69 4.37 3.57 3.31 3.31 3.62 4.14 2.96 2.98 3.35 4.14
Debt to Total Capital
49.10% 51.29% 54.14% 53.35% 54.13% 53.51% 58.40% 56.79% 57.03% 57.85% 57.18%
Short-Term Debt to Total Capital
0.69% 3.80% 3.97% 12.24% 11.64% 9.03% 8.71% 8.44% 7.87% 16.87% 17.39%
Long-Term Debt to Total Capital
48.41% 47.49% 50.17% 41.11% 42.49% 44.47% 49.69% 48.36% 49.17% 40.98% 39.78%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.07% 1.09% 1.12% 1.07% 1.02% 1.04% 1.01% 0.97% 0.91% 0.95% 0.98%
Common Equity to Total Capital
49.84% 47.63% 44.74% 45.58% 44.85% 45.45% 40.59% 42.23% 42.05% 41.20% 41.84%
Debt to EBITDA
0.00 -10.92 -14.24 55.02 32.02 19.41 18.65 12.13 7.99 10.62 9.26
Net Debt to EBITDA
0.00 -6.37 -6.65 30.38 20.52 12.45 8.63 7.50 5.51 7.34 5.54
Long-Term Debt to EBITDA
0.00 -10.11 -13.19 42.40 25.14 16.13 15.86 10.32 6.88 7.53 6.44
Debt to NOPAT
0.00 -17.51 -16.72 -19.45 -17.13 -22.23 -31.46 -67.36 -434.97 -78.01 -98.11
Net Debt to NOPAT
0.00 -10.22 -7.81 -10.74 -10.98 -14.25 -14.55 -41.66 -300.00 -53.89 -58.66
Long-Term Debt to NOPAT
0.00 -16.22 -15.50 -14.99 -13.45 -18.47 -26.77 -57.36 -374.96 -55.26 -68.26
Altman Z-Score
0.00 1.47 1.12 1.32 1.41 1.32 1.12 1.52 1.57 1.16 1.21
Noncontrolling Interest Sharing Ratio
0.00% 1.43% 2.45% 2.30% 2.15% 2.24% 2.43% 2.27% 2.17% 2.25% 2.35%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.29 0.93 0.80 0.64 0.70 0.62 0.78 0.64 0.87 0.42 0.46
Quick Ratio
1.09 0.80 0.62 0.46 0.59 0.56 0.66 0.42 0.68 0.35 0.34
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-942 0.00 -799 -832 -47 -72 -91 -84 -116 -151 -162
Operating Cash Flow to CapEx
-366.35% 96.67% 329.44% -115.18% -418.58% 239.05% 490.73% -7.35% -1,174.34% 358.36% 724.00%
Free Cash Flow to Firm to Interest Expense
-97.53 0.00 -84.58 -85.65 -4.95 -7.15 -8.78 -7.22 -9.44 -12.44 -14.53
Operating Cash Flow to Interest Expense
-5.92 2.37 9.64 -3.53 -7.22 2.87 9.26 -0.70 -7.23 2.17 5.59
Operating Cash Flow Less CapEx to Interest Expense
-7.54 -0.08 6.72 -6.60 -8.94 1.67 7.37 -10.19 -7.85 1.57 4.82
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.43 0.40 0.84 0.44 0.44 0.41 0.43 0.45 0.47 0.45
Accounts Receivable Turnover
0.00 9.62 16.07 0.00 7.25 11.74 19.83 11.77 8.27 17.53 26.33
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.86 0.82 0.00 0.88 0.84 0.84 0.84 0.86 0.87 0.89
Accounts Payable Turnover
0.00 7.68 0.00 0.00 2.36 7.51 5.67 0.00 0.00 0.00 0.72
Days Sales Outstanding (DSO)
0.00 37.93 22.71 0.00 50.35 31.09 18.41 31.02 44.15 20.82 13.86
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 47.50 0.00 0.00 154.70 48.58 64.43 0.00 0.00 0.00 503.71
Cash Conversion Cycle (CCC)
0.00 -9.57 22.71 0.00 -104.35 -17.49 -46.02 31.02 44.15 20.82 -489.85
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
899 873 762 856 953 932 822 970 1,097 1,048 955
Invested Capital Turnover
0.00 0.73 1.70 1.54 0.73 0.73 0.85 0.77 0.71 0.74 0.85
Increase / (Decrease) in Invested Capital
899 0.00 762 856 54 59 60 114 144 116 133
Enterprise Value (EV)
0.00 2,985 2,875 2,903 3,034 2,943 3,080 3,527 3,390 3,196 3,450
Market Capitalization
0.00 2,641 2,593 2,560 2,612 2,535 2,745 3,080 2,853 2,674 3,014
Book Value per Share
$9.13 $8.56 $7.74 $8.28 $8.56 $8.44 $7.77 $8.35 $8.93 $8.36 $8.12
Tangible Book Value per Share
$4.28 $3.71 $2.90 $3.44 $3.73 $3.62 $2.98 $3.57 $4.16 $3.60 $3.43
Total Capital
1,131 1,110 1,071 1,125 1,183 1,153 1,198 1,238 1,332 1,277 1,240
Total Debt
555 569 580 600 640 617 699 703 760 739 709
Total Long-Term Debt
547 527 537 462 502 513 595 599 655 523 493
Net Debt
323 332 271 331 410 396 324 435 524 510 424
Capital Expenditures (CapEx)
16 24 28 30 16 12 20 111 7.56 7.37 8.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-64 -111 -239 -164 -76 -116 -255 -184 -42 -115 -219
Debt-free Net Working Capital (DFNWC)
62 26 -30 -2.20 40 -3.32 12 -30 72 -2.99 -50
Net Working Capital (NWC)
55 -16 -72 -140 -98 -108 -93 -135 -33 -218 -266
Net Nonoperating Expense (NNE)
-37 9.70 15 -4.91 -3.54 6.07 10 0.00 -2.07 6.63 12
Net Nonoperating Obligations (NNO)
323 332 271 331 410 396 324 435 524 510 424
Total Depreciation and Amortization (D&A)
21 16 15 17 19 12 13 21 23 18 17
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -17.36% -36.94% -24.80% -11.19% -17.49% -37.92% -26.17% -5.86% -15.64% -28.97%
Debt-free Net Working Capital to Revenue
0.00% 4.14% -4.62% -0.33% 5.91% -0.50% 1.76% -4.30% 9.98% -0.41% -6.67%
Net Working Capital to Revenue
0.00% -2.44% -11.20% -21.21% -14.38% -16.22% -13.75% -19.17% -4.51% -29.81% -35.16%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.10) ($0.52) ($0.83) $0.47 $0.16 ($0.30) ($0.66) $0.47 $0.48 ($0.66) ($0.63)
Adjusted Weighted Average Basic Shares Outstanding
61.72M 61.87M 61.94M 61.97M 62.14M 62.57M 62.59M 62.76M 62.92M 63.91M 64.14M
Adjusted Diluted Earnings per Share
($0.10) ($0.52) ($0.83) $0.46 $0.16 ($0.29) ($0.66) $0.46 $0.47 ($0.64) ($0.63)
Adjusted Weighted Average Diluted Shares Outstanding
61.72M 61.87M 61.94M 61.97M 62.14M 62.57M 62.59M 62.76M 62.92M 63.91M 64.14M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
61.72M 61.87M 61.94M 61.97M 62.14M 62.57M 62.59M 62.76M 62.92M 63.91M 64.14M
Normalized Net Operating Profit after Tax (NOPAT)
11 -23 -37 24 4.48 -13 -31 29 28 -35 -29
Normalized NOPAT Margin
4.05% -33.44% -98.84% 8.56% 1.54% -25.05% -65.91% 9.44% 9.00% -56.86% -40.10%
Pre Tax Income Margin
0.81% -56.57% -149.48% 10.60% 3.41% -39.16% -114.16% 13.37% 13.42% -87.76% -70.30%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.36 -3.24 -5.36 2.80 0.86 -1.57 -4.18 3.73 3.31 -3.86 -3.59
NOPAT to Interest Expense
-4.46 -2.35 -3.88 2.49 0.68 -1.30 -3.01 2.53 2.28 -2.87 -2.59
EBIT Less CapEx to Interest Expense
-1.97 -5.69 -8.28 -0.27 -0.86 -2.77 -6.07 -5.76 2.69 -4.47 -4.36
NOPAT Less CapEx to Interest Expense
-6.07 -4.80 -6.81 -0.58 -1.05 -2.50 -4.89 -6.96 1.67 -3.47 -3.36
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Atlanta Braves Holdings, Inc. (NASDAQ:BATRK) showed a mixed but generally stabilizing financial profile in Q1 2026. Revenue remained solid for the quarter, but the company still posted a sizable net loss as operating costs and interest expense outweighed operating income. On the positive side, cash from operations turned strong, helping support liquidity even though debt remains a meaningful overhang.

  • Operating cash flow was strong in Q1 2026. The company generated $62.5 million of cash from operations, a major improvement from the $26.4 million generated in Q4 2025 and the negative operating cash flow in Q3 2025.
  • Cash balance improved meaningfully. Cash and equivalents rose to $135.2 million at March 31, 2026, up from $82.2 million at the end of Q3 2025.
  • Revenue remained resilient year over year. Q1 2026 revenue was $72.0 million versus $47.2 million in Q1 2025, showing a strong increase.
  • Quarterly operating income improved sharply versus the prior year. Operating loss narrowed to $41.3 million in Q1 2026 from a $44.5 million loss in Q1 2025, and it was far better than the heavy losses seen in late 2024 and early 2024.
  • Liquidity remains supported by a sizable asset base. Total assets were $1.69 billion, including nearly $874 million of net property and equipment and more than $116 million of long-term investments.
  • Capital spending remained controlled. Property, plant and equipment purchases were $8.6 million in Q1 2026, below the levels seen in several prior quarters.
  • Depreciation remains a steady non-cash expense. Depreciation was $17.1 million in Q1 2026, which is meaningful but not unusual for a capital-intensive business.
  • The company is still unprofitable. Q1 2026 net loss was $40.4 million, or $(0.63) per share, so earnings remain well below breakeven.
  • Debt load is still high. Short-term debt was $215.7 million and long-term debt was $493.4 million, for total debt of roughly $709 million.
  • Interest expense continues to pressure results. Q1 2026 interest expense was $11.2 million, which is a significant burden relative to operating income.

Trend overview: Atlanta Braves Holdings’ results over the last several quarters show a pattern of strong seasonal revenue with highly volatile profitability. Revenue improved from the 2024 off-season levels into 2025 and held up in Q1 2026, but operating margins remain inconsistent because of large other operating expenses and interest costs. Cash generation is a clear bright spot, especially in Q1 2026, but investors should keep an eye on leverage and the company’s ability to convert revenue growth into sustained profits.

07/21/26 02:04 AM ETAI Generated. May Contain Errors.

Atlanta Braves Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Atlanta Braves' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Atlanta Braves' net income appears to be on a downward trend, with a most recent value of -$23.28 million in 2025, falling from -$34.17 million in 2022. The previous period was -$31.27 million in 2024. View Atlanta Braves' forecast to see where analysts expect Atlanta Braves to go next.

Atlanta Braves' total operating income in 2025 was -$13.53 million, based on the following breakdown:
  • Total Gross Profit: $732.49 million
  • Total Operating Expenses: $746.02 million

Over the last 3 years, Atlanta Braves' total revenue changed from $588.56 million in 2022 to $732.49 million in 2025, a change of 24.5%.

Atlanta Braves' total liabilities were at $1.08 billion at the end of 2025, a 9.0% increase from 2024, and a 9.6% decrease since 2022.

In the past 3 years, Atlanta Braves' cash and equivalents has ranged from $99.88 million in 2025 to $150.66 million in 2022, and is currently $99.88 million as of their latest financial filing in 2025.

Over the last 3 years, Atlanta Braves' book value per share changed from 0.00 in 2022 to 8.36 in 2025, a change of 836.0%.



Financial statements for NASDAQ:BATRA last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners